Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the AMPK/TFEB signaling pathway.
Saved in:
| Published in: | Journal of Food and Drug Analysis |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553018259013632 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Journal of Food and Drug Analysis |
| description | |
| discipline_display | Food and Food Industries |
| discipline_facet | Food and Food Industries |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:71736 |
| institution | FRELIP |
| journal_source_facet | Journal of Food and Drug Analysis |
| last_indexed | 2026-06-20T21:30:19.360Z |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | Selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the AMPK/TFEB signaling pathway. Food and Food Industries General Food and Food Industries |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Food and Food Industries General Food and Food Industries |
| subject_facet | Food and Food Industries General Food and Food Industries |
| title | Selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the AMPK/TFEB signaling pathway. |
| title_alt | El inhibidor selectivo del cotransportador de sodio-glucosa tipo 2, empagliflozina, mejora la miocardiopatía diabética activando la vía de señalización AMPK/TFEB L'empagliflozine, inhibiteur sélectif du cotransporteur sodium-glucose de type 2, améliore la cardiomyopathie diabétique en activant la voie de signalisation AMPK/TFEB O inibidor seletivo do cotransportador sódio-glicose 2 empagliflozina melhora a cardiomiopatia diabética ativando a via de sinalização AMPK/TFEB |
| title_auth | Selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the AMPK/TFEB signaling pathway. |
| title_es_txt | El inhibidor selectivo del cotransportador de sodio-glucosa tipo 2, empagliflozina, mejora la miocardiopatía diabética activando la vía de señalización AMPK/TFEB |
| title_fr_txt | L'empagliflozine, inhibiteur sélectif du cotransporteur sodium-glucose de type 2, améliore la cardiomyopathie diabétique en activant la voie de signalisation AMPK/TFEB |
| title_full | Selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the AMPK/TFEB signaling pathway. |
| title_fullStr | Selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the AMPK/TFEB signaling pathway. |
| title_full_unstemmed | Selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the AMPK/TFEB signaling pathway. |
| title_pt_txt | O inibidor seletivo do cotransportador sódio-glicose 2 empagliflozina melhora a cardiomiopatia diabética ativando a via de sinalização AMPK/TFEB |
| title_short | Selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the AMPK/TFEB signaling pathway. |
| title_sort | selective sodium-glucose cotransporter two inhibitor empagliflozin ameliorates diabetic cardiomyopathy by activating the ampk/tfeb signaling pathway. |
| topic | Food and Food Industries General Food and Food Industries |
| url | https://www.jfda-online.com/journal/vol33/iss4/6 |